Why the Atomo Diagnostics (ASX:AT1) share price closed 7% down today

The Atomo Diagnostics (ASX: AT1) share price fell more than 7% today following the release of the company’s first-half results.

| More on:
falling healthcare asx share represented by doctor with head in hands

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atomo Diagnostics Ltd (ASX: AT1) share price closed 7.27% lower this afternoon after the company posted its half-year results earlier today.

The medical device business posted gains in many of its key financial metrics, however, the benefits did not carry over to the Atomo Diagnostics share price during trading.

Here’s a rundown of the company’s half-yearly results for the period ending 31 December 2020.

Atomo Diagnostics posts gains across key metrics

The company reported a revenue increase of 389% to $4.58 million for the first half of FY21. 

Gross profit was also up, jumping 278% over the prior corresponding period (pcp) to $2.52 million.

Atomo reported a negative net operating cash flow of $193,300 for the period, which is a 91% improvement on the pcp.

The business increased the number of devices it produces monthly. During the first half of FY21, it progressed from producing 750k devices a month to 1.6 million.

Cash and cash equivalents amounted to $24.7 million at 31 December 2020, which is a dip down from the $27.1 million reported at 30 June 2020.

Atomo noted that it invested a total of $2.29 million in R&D activities over the 1H FY21 period.

Outlook

As 2021 progresses, the company has outlined a variety of priorities. Some of these include pursuing relevant FDA approvals, driving growth in the US and Australian markets, and continuing to develop digital enhancements that support the use of Atomo products.

The company is also anticipating increased demand for its HIV self-test device.

Atomo will continue to invest in R&D activities that support the development of new products and help reveal future market opportunities.

Finally, Atomo noted that the coronavirus pandemic had limited impact on the business outside of causing a few minor delays.

About the Atomo Diagnostics share price

The Atomo Diagnostics share price has dropped 31.25% in the past 6 months.

The company’s market capitalisation is $114.2 million, with 407.9 million shares outstanding.

Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Young woman in yellow striped top with laptop raises arm in victory
Share Gainers

These were the best performing ASX 200 shares in June

These ASX 200 shares defied the market selloff and stormed higher...

Read more »

oil and gas worker checks phone on site in front of oil and gas equipment
Energy Shares

Santos shares go cold despite energy regulator outlining ‘crucial’ role gas will play for decades

The Australian Energy Market Operator has released a 30-year plan for investment to enable the transition to renewables.

Read more »

ASX shares COVID the words crash with a declining arrow on top
Share Fallers

These were the worst performing ASX 200 shares in June

It was a bad month for the ASX 200 but an even worse month for these shares...

Read more »

A young boy dressed in a suit and glasses that are too big for him sits at a desk and holds up a trophy representing the top 10 ASX shares today
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Thursday.

Read more »

A man is deep in thought while looking at graph and rising and falling percentages.
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Thursday

We take a look at the most traded ASX 200 shares by volume today.

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
Industrials Shares

Why is the Electro Optic Systems share price hitting a new 52-week low?

Selling pressure has rolled over into today's session after Wednesday's collapse

Read more »

a woman sits in comtemplation with superimposed images of piles of gold coins, graphs and star-like lights above her head as though she is thinking about investment options.
Broker Notes

2 ASX 200 shares with enough pricing power to battle inflation: Expert

An expert has tipped Transurban and Resmed shares as potential inflation safe havens.

Read more »

Miner standing in a mine site with his arms crossed.
Materials Shares

Guess which 2 ASX mining shares are soaring more than 15% on new discoveries today?

What's driving up the share price of these explorers today?

Read more »